Literature DB >> 12404287

Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features.

Takuji Okusaka1, Shuichi Okada, Hideki Ueno, Masafumi Ikeda, Kazuaki Shimada, Junji Yamamoto, Tomoo Kosuge, Susumu Yamasaki, Noriyoshi Fukushima, Michiie Sakamoto.   

Abstract

BACKGROUND: It is not rare to find satellite lesions in patients with small hepatocellular carcinoma (HCC). The purpose of this study was to elucidate the factors associated with satellite lesions in these patients.
METHODS: We investigated the prevalence of satellite lesions, the relationship of clinicopathologic factors to satellite lesions, and the distance from the main tumor to the satellite lesion in 149 patients. Patients, who had a solitary HCC of 3.0 cm or less in diameter but no satellite lesions on preoperative imaging procedures, underwent potentially curative resection. The main tumors were macroscopically classified into four groups: early HCC, a vaguely nodular type showing preservation of the preexisting liver structure; single nodular type; single nodular type with extranodular growth; and confluent multinodular type.
RESULTS: Of 149 resected specimens, 28 (19%) showed satellite lesions. Of the clinicopathologic factors investigated, the macroscopic type and tumor differentiation were significantly associated with the prevalence of satellite lesions. Both the single nodular type with extranodular growth and the confluent multinodular type showed satellite lesions more frequently than the early HCC and the single nodular type. A significantly higher prevalence of satellite lesions was observed in poorly differentiated HCC than in well and moderately differentiated HCC. The satellite lesions were located 0.5 cm or less from the main tumor in 8 (33%) specimens, 0.6-1.0 cm in 12 (50%), and 1.1-2.0 cm in 4 (17%). No identifiable factors were significantly related to the distance from the main tumor to the satellite lesion. However, all satellite lesions located more than 1.0 cm from the main tumor coexisted with poorly differentiated HCC, which were the single nodular type with extranodular growth or the confluent multinodular type.
CONCLUSION: In the single nodular type with extranodular growth, confluent multinodular type, and poorly differentiated HCC, extensive treatment achieving a large safety margin and/or frequent posttreatment follow-up examinations may be needed because of the high prevalence of satellite lesions. Copyright 2002 American Cancer Society.

Entities:  

Mesh:

Year:  2002        PMID: 12404287     DOI: 10.1002/cncr.10892

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  56 in total

1.  Prediction of the histopathological grade of hepatocellular carcinoma using qualitative diffusion-weighted, dynamic, and hepatobiliary phase MRI.

Authors:  Chansik An; Mi-Suk Park; Hyae-Min Jeon; Yeo-Eun Kim; Woo-Suk Chung; Yong Eun Chung; Myeong-Jin Kim; Ki Whang Kim
Journal:  Eur Radiol       Date:  2012-03-22       Impact factor: 5.315

Review 2.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-09       Impact factor: 11.105

3.  Drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma: does size really matter?

Authors:  Sieh-Yang Lee; Hsin-You Ou; Chun-Yen Yu; Tung-Liang Huang; Leo Leung-Chit Tsang; Yu-Fan Cheng
Journal:  Diagn Interv Radiol       Date:  2020-05       Impact factor: 2.630

4.  Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.

Authors:  Minghui Wu; Hongna Tan; Fei Gao; Jinjin Hai; Peigang Ning; Jian Chen; Shaocheng Zhu; Meiyun Wang; Shewei Dou; Dapeng Shi
Journal:  Eur Radiol       Date:  2018-11-07       Impact factor: 5.315

Review 5.  Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI.

Authors:  Yasunori Minami; Naoshi Nishida; Masatoshi Kudo
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

6.  Microwave Ablation: Comparison of Simultaneous and Sequential Activation of Multiple Antennas in Liver Model Systems.

Authors:  Colin M Harari; Michelle Magagna; Mariajose Bedoya; Fred T Lee; Meghan G Lubner; J Louis Hinshaw; Timothy Ziemlewicz; Christopher L Brace
Journal:  Radiology       Date:  2015-07-02       Impact factor: 11.105

7.  Simultaneous integrated boost-intensity modulated radiation therapy for inoperable hepatocellular carcinoma.

Authors:  Tae Hyun Kim; Joong-Won Park; Yeon-Joo Kim; Bo Hyun Kim; Sang Myung Woo; Sung Ho Moon; Sang Soo Kim; Woo Jin Lee; Dae Yong Kim; Chang-Min Kim
Journal:  Strahlenther Onkol       Date:  2014-03-18       Impact factor: 3.621

Review 8.  Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status.

Authors:  Lumin Chen; Jihong Sun; Xiaoming Yang
Journal:  Cancer Lett       Date:  2015-10-22       Impact factor: 8.679

9.  Evaluation of cancer treatment in the abdomen: Trends and advances.

Authors:  Silanath Peungjesada; Hubert H Chuang; Srinivasa R Prasad; Haesun Choi; Evelyne M Loyer; Yulia Bronstein
Journal:  World J Radiol       Date:  2013-03-28

10.  Radiofrequency ablation of hepatic tumours: effect of post-ablation margin on local tumour progression.

Authors:  Chang-Hsien Liu; Ronald S Arellano; Raul N Uppot; Anthony E Samir; Debra A Gervais; Peter R Mueller
Journal:  Eur Radiol       Date:  2009-09-16       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.